Bio-Rad Laboratories (BIO-B) Return on Capital Employed (2010 - 2026)
Bio-Rad Laboratories (BIO-B) reported Return on Capital Employed of 0.62% for Q1 2026, down 511.0% year-over-year from 0.15% in Q1 2025, and up 26.69% on a QoQ basis from 0.49% in Q4 2025.
Bio-Rad Laboratories (BIO-B) has 17 years of Return on Capital Employed data on file, last reported at 0.62% in Q1 2026.
- Quarterly Return on Capital Employed fell 511.0% year-over-year to 0.62% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.62% (down 511.0% YoY) and the FY2025 annual result came in at 0.5%, down 588.0% from the prior year.
- Return on Capital Employed grew to 0.62% in Q1 2026 per BIO-B's latest filing, from 0.49% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 8.84% in Q4 2022 and bottomed at 100.1% in Q1 2024.
- The 5-year median for Return on Capital Employed is 4.15% (2022), against an average of 3.0%.
- The widest annual swing landed in 2024, when Return on Capital Employed tumbled 10648 bps; it then surged 10583 bps in 2025.
- Tracing BIO-B's Return on Capital Employed over 5 years: stood at 8.84% in 2022, then dropped by 30 bps to 6.23% in 2023, then slumped by 1708 bps to 100.1% in 2024, then surged by 100 bps to 0.49% in 2025, then increased by 27 bps to 0.62% in 2026.
- Per Business Quant, the three latest BIO-B Return on Capital Employed figures stand at 0.62% (Q1 2026), 0.49% (Q4 2025), and 2.38% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 7.36% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 11.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 7.62% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 24.24% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 9.30% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 11.57% |
| 10 | Bio-Rad Laboratories | - | - | 309.40 Mn | 0.62% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.62% |
| Dec 31, 2025 | 0.49% |
| Sep 30, 2025 | 2.38% |
| Jun 30, 2025 | 4.75% |
| Mar 31, 2025 | 5.73% |
| Mar 31, 2024 | -100.10% |
| Dec 31, 2023 | 6.23% |
| Sep 30, 2023 | 3.17% |
| Jun 30, 2023 | 2.98% |
| Mar 31, 2023 | 6.38% |
| Dec 31, 2022 | 8.84% |
| Sep 30, 2022 | 4.08% |
| Jun 30, 2022 | 4.21% |
| Mar 31, 2022 | 8.22% |
| Dec 31, 2021 | 5.32% |
| Sep 30, 2021 | 3.36% |
| Jun 30, 2021 | 3.74% |
| Mar 31, 2021 | 6.83% |
| Dec 31, 2020 | 7.55% |
| Sep 30, 2020 | 2.93% |
| Jun 30, 2020 | 2.87% |
| Mar 31, 2020 | 3.31% |
| Dec 31, 2019 | 3.43% |
| Sep 30, 2019 | -0.81% |
| Jun 30, 2019 | -1.14% |
| Mar 31, 2019 | -1.56% |
| Dec 31, 2018 | -1.81% |
| Sep 30, 2018 | 2.78% |
| Jun 30, 2018 | 2.94% |
| Mar 31, 2018 | 2.64% |
| Dec 31, 2017 | 2.93% |
| Sep 30, 2017 | 0.95% |
| Jun 30, 2017 | 0.53% |
| Mar 31, 2017 | 1.36% |
| Dec 31, 2016 | 1.20% |
| Sep 30, 2016 | 3.69% |
| Jun 30, 2016 | 4.09% |
| Mar 31, 2016 | 4.58% |
| Dec 31, 2015 | 5.13% |
| Sep 30, 2015 | 4.99% |
| Jun 30, 2015 | 5.24% |
| Mar 31, 2015 | 5.62% |
| Dec 31, 2014 | 5.14% |
| Sep 30, 2014 | 5.19% |
| Jun 30, 2014 | 4.96% |
| Mar 31, 2014 | 5.28% |
| Dec 31, 2013 | 5.95% |
| Sep 30, 2013 | 6.31% |
| Jun 30, 2013 | 7.27% |
| Mar 31, 2013 | 8.04% |
| Dec 31, 2012 | 8.98% |
| Sep 30, 2012 | 10.33% |
| Jun 30, 2012 | 10.78% |
| Mar 31, 2012 | 10.84% |
| Dec 31, 2011 | 11.86% |
| Sep 30, 2011 | 11.07% |
| Jun 30, 2011 | 11.36% |
| Mar 31, 2011 | 11.25% |
| Dec 31, 2010 | 12.88% |
| Sep 30, 2010 | 11.97% |